Cited 0 times in Scipus Cited Count

Surgical Methods for Radioiodine Refractory Thyroid Cancer

Other Title
방사성 요오드 저항성 갑상선암에서 수술적 치료의 역할
서, 수한 | 이, 정훈  | 소, 의영
Korean Journal of Endocrine Surgery, 13(1). : 1-7, 2013
Journal Title
Korean Journal of Endocrine Surgery
Most patients with thyroid cancer (of follicular cell origin) are successfully managed with a combination of surgery, radioactive iodine (131I-RAI), and suppression of thyroid-stimulating hormone with thyroid hormone replacement, obtaining survival rates approaching 90% at 20 years. Although the prognosis of patients with differentiated thyroid carcinoma (DTC) is favorable, recurrence occurs in up to 30% patients. In addition, many patients with recurrent or metastatic disease, as well as those with less differentiated tumors, will have a much poorer prognosis and lose their ability to concentrate functional iodine and are therefore not targeted by 131I-RAI therapy. There are many treatment options but no definitive treatment for radioiodine refractory thyroid cancer. This paper will discuss the roles of surgical treatment for patients with radioiodine refractory thyroid cancer.
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Surgery
Ajou Authors
소, 의영  |  이, 정훈
Files in This Item:
Korean Journal of Endocrine Surgery_13(1)_1-7.pdfDownload


해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.